NO20071806L - Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel. - Google Patents

Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.

Info

Publication number
NO20071806L
NO20071806L NO20071806A NO20071806A NO20071806L NO 20071806 L NO20071806 L NO 20071806L NO 20071806 A NO20071806 A NO 20071806A NO 20071806 A NO20071806 A NO 20071806A NO 20071806 L NO20071806 L NO 20071806L
Authority
NO
Norway
Prior art keywords
site
active ingredient
tablets
time controlled
controlled gastrointestinal
Prior art date
Application number
NO20071806A
Other languages
English (en)
Inventor
Achim Schaffler
Original Assignee
Nitec Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102004043863A external-priority patent/DE102004043863A1/de
Application filed by Nitec Pharma Ag filed Critical Nitec Pharma Ag
Publication of NO20071806L publication Critical patent/NO20071806L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse beskriver en farmasøytisk doseringsform med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.
NO20071806A 2004-09-10 2007-04-03 Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel. NO20071806L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102004043863A DE102004043863A1 (de) 2004-09-10 2004-09-10 Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
US11/216,469 US20060057200A1 (en) 2004-09-10 2005-09-01 Tablets with site- and time-controlled gastrointestinal release of active ingredient
PCT/EP2005/009726 WO2006027266A1 (en) 2004-09-10 2005-09-09 Tablets with site time-controlled gastrointestinal release of active ingredient

Publications (1)

Publication Number Publication Date
NO20071806L true NO20071806L (no) 2007-06-08

Family

ID=36036090

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20071806A NO20071806L (no) 2004-09-10 2007-04-03 Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.

Country Status (7)

Country Link
EP (1) EP1807058A1 (no)
JP (1) JP5134955B2 (no)
KR (1) KR101363563B1 (no)
AU (1) AU2005281797B2 (no)
CA (1) CA2579732C (no)
NO (1) NO20071806L (no)
WO (1) WO2006027266A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum
ES2400446T5 (es) * 2006-08-03 2017-03-13 Horizon Pharma Ag Tratamiento con glucocorticoides de liberación retardada de una enfermedad reumática
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
WO2010084188A1 (en) 2009-01-26 2010-07-29 Nitec Pharma Ag Delayed-release glucocorticoid treatment of asthma
EA202190820A1 (ru) 2012-09-26 2021-10-29 Арагон Фармасьютикалз, Инк. Антиандрогены для лечения неметастатического кастрационно-резистентного рака простаты
JOP20200097A1 (ar) * 2013-01-15 2017-06-16 Aragon Pharmaceuticals Inc معدل مستقبل أندروجين واستخداماته
CA3031705A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Treatment of prostate cancer with niraparib
WO2019078920A1 (en) 2017-10-16 2019-04-25 Aragon Pharmaceuticals, Inc. ANTI-ANDROGENS FOR THE TREATMENT OF NON-METASTATIC RESISTANT PROSTATE CANCER
JP2021120357A (ja) * 2020-01-30 2021-08-19 サンノーバ株式会社 錠剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2521848B2 (ja) * 1990-07-02 1996-08-07 ベーリンガー マンハイム ゲーエムベーハー 成形され、圧縮された徐放性単位投薬形態の調製法およびこうして得られた圧縮単位投薬形態
US5811388A (en) * 1995-06-07 1998-09-22 Cibus Pharmaceutical, Inc. Delivery of drugs to the lower GI tract
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
JP2001010950A (ja) * 1999-06-29 2001-01-16 Taiyo Yakuhin Kogyo Kk 安定で良好な薬物放出を有する医薬組成物
DE10012555A1 (de) * 2000-03-15 2001-09-20 Merck Patent Gmbh Glucocorticoide in einer Modified Release-Formulierung
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
CN1499960A (zh) * 2001-03-13 2004-05-26 ����˹��ҩ�﹫˾ 时间治疗剂型
WO2003075919A1 (fr) * 2002-03-14 2003-09-18 Daiichi Suntory Pharma Co.,Ltd. Comprime contenant du chlorhydrate de pilsicainide (voie seche)
US20070148229A1 (en) * 2003-04-24 2007-06-28 Jagotec Ag Tablet with coloured core
DE102004043863A1 (de) * 2004-09-10 2006-03-16 Nitec Pharma Ag Tabletten mit orts- und zeitgesteuerter Wirkstofffreisetzung im Gastrointestinum

Also Published As

Publication number Publication date
JP2008512419A (ja) 2008-04-24
JP5134955B2 (ja) 2013-01-30
CA2579732A1 (en) 2006-03-16
KR20070098989A (ko) 2007-10-08
EP1807058A1 (en) 2007-07-18
WO2006027266A1 (en) 2006-03-16
KR101363563B1 (ko) 2014-02-14
AU2005281797A1 (en) 2006-03-16
CA2579732C (en) 2014-08-12
AU2005281797B2 (en) 2011-07-07

Similar Documents

Publication Publication Date Title
MX2007002898A (es) Tableta con liberacion gastrointestinal controlada en sitio y tiempo del ingrediente activo.
NO20071806L (no) Tabletter med steds- og tidsregulert gastrointestinal frigivelse av aktiv bestanddel.
IS8060A (is) Truflanaþolið skammtaform til íkomu um húð sem inniheldur virkan efnisþátt og andstæðan efnisþátt við fjarhlið virka efnislagsins
NO20064041L (no) Substituerte pyrazolin sammensetninger, deres fremstilling og anvendelse som medikamenter
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20053224D0 (no) Patient controlled drug administration device.
BRPI0516830A (pt) composições de droga de liberação sustentada convenientemente implantáveis
DOP2009000026A (es) Formas de dosificacion farmaceutica oral resistente a la manipulacion que comprende un analgesico opioide
UA103347C2 (ru) Фармацевтическая препаративная форма, которая содержит нифедипин или низолдипин и антагонист ангиотензина-ii и/или диуретик
DK1957110T3 (da) Fremgangsmåde til fremstilling af tygbare doseringsformer til lægemiddeladministration og produkter dermed
ZA200605631B (en) Directly compressible pharmaceutical composition for the oral administration of CCI-779
DK1641438T3 (da) Fremgangsmåde til fremstilling af den amorfe form af et lægemiddel
HK1124558A1 (en) Pharmaceutical dosage form containing an active principle combination of nifedipine and/or nisoldipine and of an angiotensin ii antagonist
EA201201202A1 (ru) Пероральная фармацевтическая композиция, содержащая этексилат дабигатрана
ZA200709788B (en) Cannabinold active pharmaceutical ingredient for Improved dosage forms
WO2011151722A3 (en) Methods and compositions for oral pharmaceutical therapy
TW200638927A (en) Bambuterol and integrin inhibitor combination
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
UY31662A1 (es) Composiciones de tabletas de ranitidina de desintegracion oral y sus metodos de elaboracion.
FI20000780A (fi) Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
DE602006012310D1 (de) An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
ATE460934T1 (de) Pharmazeutische zubereitungen von ciprofloxacin
FR2915684B1 (fr) Particules a base de polyelectrolytes et de principe actif a liberation modifiee et formulations pharmaceutiques contenant ces particules
IS7383A (is) Skammtaform með stýrða lyflosun til inngjafar
TR200301553A1 (tr) İrbesartan etken maddesi içeren yeni oral farmasötik formülasyonlar

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application